Silexion Therapeutics Corp. (SLXN)
0.3606
-0.03
(-8.50%)
USD |
NASDAQ |
Aug 24, 16:00
0.3602
0.00 (0.00%)
After-Hours: 20:00
Silexion Therapeutics Total Assets (Quarterly) : 4.246M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.246M |
| March 31, 2026 | 4.602M |
| December 31, 2025 | 7.215M |
| September 30, 2025 | 11.61M |
| June 30, 2025 | 5.797M |
| March 31, 2025 | 8.308M |
| December 31, 2024 | 2.863M |
| September 30, 2024 | 3.087M |
| June 30, 2024 | 5.967M |
| March 31, 2024 | 5.842M |
| December 31, 2023 | 5.256M |
| September 30, 2023 | 5.671M |
| Date | Value |
|---|---|
| June 30, 2023 | 27.48M |
| March 31, 2023 | 26.96M |
| December 31, 2022 | 116.80M |
| September 30, 2022 | 116.03M |
| June 30, 2022 | 115.40M |
| March 31, 2022 | 115.48M |
| December 31, 2021 | 115.41M |
| September 30, 2021 | 115.57M |
| June 30, 2021 | 115.80M |
| March 31, 2021 | 115.96M |
| December 31, 2020 | 0.1294M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| BioLineRx Ltd. | 38.80M |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 383.16M |
| Can-Fite BioPharma Ltd. | -- |
| Galmed Pharmaceuticals Ltd. | 16.03M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.202M |
| Shareholders Equity (Quarterly) | 0.044M |
| Debt to Equity Ratio | 32.05 |
| Current Ratio | 0.9409 |
| Net Debt Paydown Yield | 13.77% |